These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31566105)

  • 1. Blood Microbiota Modification After Myocardial Infarction Depends Upon Low-Density Lipoprotein Cholesterol Levels.
    Amar J; Lelouvier B; Servant F; Lluch J; Burcelin R; Bongard V; Elbaz M
    J Am Heart Assoc; 2019 Oct; 8(19):e011797. PubMed ID: 31566105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
    Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
    Bangalore S; Fayyad R; Messerli FH; Laskey R; DeMicco DA; Kastelein JJ; Waters DD
    Am J Cardiol; 2017 Feb; 119(3):379-387. PubMed ID: 27939230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
    Sabatine MS; De Ferrari GM; Giugliano RP; Huber K; Lewis BS; Ferreira J; Kuder JF; Murphy SA; Wiviott SD; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR
    Circulation; 2018 Aug; 138(8):756-766. PubMed ID: 29626068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
    Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction.
    Zhou X; Li J; Guo J; Geng B; Ji W; Zhao Q; Li J; Liu X; Liu J; Guo Z; Cai W; Ma Y; Ren D; Miao J; Chen S; Zhang Z; Chen J; Zhong J; Liu W; Zou M; Li Y; Cai J
    Microbiome; 2018 Apr; 6(1):66. PubMed ID: 29615110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
    Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
    Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012.
    Albrektsen G; Heuch I; Løchen ML; Thelle DS; Wilsgaard T; Njølstad I; Bønaa KH
    Atherosclerosis; 2017 Jun; 261():52-59. PubMed ID: 28448842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.
    Tang TWH; Chen HC; Chen CY; Yen CYT; Lin CJ; Prajnamitra RP; Chen LL; Ruan SC; Lin JH; Lin PJ; Lu HH; Kuo CW; Chang CM; Hall AD; Vivas EI; Shui JW; Chen P; Hacker TA; Rey FE; Kamp TJ; Hsieh PCH
    Circulation; 2019 Jan; 139(5):647-659. PubMed ID: 30586712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemias have a detrimental effect on left ventricular systolic function in patients with a first acute myocardial infarction.
    Wang TD; Wu CC; Chen WJ; Lee CM; Chen MF; Liau CS; Sung FC; Lee YT
    Am J Cardiol; 1998 Mar; 81(5):531-7. PubMed ID: 9514445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance and treatment of dyslipidemia in the post-infarct patient: can a nurse-led management approach make a difference?
    Lapointe F; Lepage S; Larrivée L; Maheux P
    Can J Cardiol; 2006 Jul; 22(9):761-7. PubMed ID: 16835670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group.
    Shamshirian A; Alizadeh-Navaei R; Abedi S; Jafarpour H; Fazli H; Hosseini S; Hessami A; Karimifar K; Yosefi S; Zahedi M; Motamen S; Ghorbanpour A; Zarandi B; Esfahani A; Rostamian-Moghaddam Y; Mehdipour S; Heydari K; Aghajanian S; Mehdi SP; Azad A; Azizi S
    Ethiop J Health Sci; 2020 Jan; 30(1):5-12. PubMed ID: 32116427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.
    Cheng KH; Chu CS; Lin TH; Lee KT; Sheu SH; Lai WT
    Crit Care Med; 2015 Jun; 43(6):1255-64. PubMed ID: 25738856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol Levels Decrease soon after Acute Myocardial Infarction.
    Rott D; Klempfner R; Goldenberg I; Leibowitz D
    Isr Med Assoc J; 2015 Jun; 17(6):370-3. PubMed ID: 26233997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.
    Szarek M; Steg PG; DiCenso D; Bhatt DL; Bittner VA; Budaj A; Diaz R; Goodman SG; Gotcheva N; Jukema JW; Pordy R; Roe MT; Sourdille T; White HD; Xavier D; Zeiher AM; Schwartz GG
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005858. PubMed ID: 31707826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels.
    Pischon T; Möhlig M; Hoffmann K; Spranger J; Weikert C; Willich SN; Pfeiffer AF; Boeing H
    Eur J Epidemiol; 2007; 22(7):429-38. PubMed ID: 17557140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of low-density lipoprotein cholesterol target achievement rates through cardiac rehabilitation for patients after ST elevation myocardial infarction or non-ST elevation myocardial infarction in Germany: Results of the PATIENT CARE registry.
    Schwaab B; Zeymer U; Jannowitz C; Pittrow D; Gitt A
    Eur J Prev Cardiol; 2019 Feb; 26(3):249-258. PubMed ID: 30509144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.